Saturday, May 17, 2008
Independent, unbiased view by market experts with excellent track record. Trading strategies with entry - exit points of view. Take an informed decision.


Investment Idea
Sep 18 2007 10:17AM
Zylog System Limited

Zylog System Limited RECOMMENDATION: BUY

Price: Rs. 445 Target Price: Rs. 631

Incorporated in 1995, Zylog System Limited (ZSL) is a credible midsized IT services and Solutions company, with strong established presence in U.S., U.K., Singapore and India. Since 1995, Zylog has been offering a range of IT services and solutions to its global customers across multiple verticals like Banking, Insurance, Telecom, Manufacturing, Retail, Healthcare etc. In 1998, ZSL has started SI/VAR (Value added resellers) Partnership practice, making headway into the large account deals.

In the past five years, ZSL has made five inorganic initiatives; In 2002 ZSL has acquired three businesses namely Silver Spring Technologies (MD), Schumacher Consulting (MA) and Schmidt Systems (VA) primarily to expand its Business Intelligence, Data Warehousing and Application Integration solutions. Though these acquisitions are small, over the years these acquisitions has enriched ZSL offering and contributed close to 28% of the total consolidated revenues for FY07.

ZSL has got significant domain expertise in BFSI (34% of FY07) and Telecom (22% of FY07). Strong domain expertise and gamut of services offering, has enabled ZSL to garner marquee cliental across the verticals like MCI Communications, Barclays Capital, Pfizer, which are few of its key customers. ZSL's strong presence & core expertise in the BFSI and Telecom sector has enabled its to identify world class products, such as Z*Connect (Wireless Messaging Server ) , Z*PRISM (A Real Time Transaction Server), RTGS Pay Manager - RTGS Payment Hub & Intra Day Liquidity Module, insured Vehicle Accident Recovery system (iVARs), Claims Management System (CMS) etc.

ZSL's focus on partnerships model has yielded good results, with consolidated revenues having registered a 66% CAGR over FY05-07and for the same period net profit grew at a CAGR of 78%. ZSL has used the inorganic route effectively to strengthen new areas like Business Intelligence, Data Warehousing and Application Integration Solutions.

We expect a 42% revenue CAGR and 44% EPS CAGR for ZSL over FY07-09. The ZSL stock trades at 6x earnings and 3.5 x EV/EBITDA FY09E, which look atractive. We Initiate coverage with a BUY rating and with a price target of Rs 631, at our target price stock will be valued at 9x FY09E earnings and 5x EV/EBITDA FY09E.

 

 

Click here to download full report

 

Reliance Money Disclaimer


Previous Research Reports

Dec 17 2007 11:17AM
KLG Systel Ltd
KSL is well positioned to cater to the distribution market with upcoming increased demand from the Distribution Automation business in the country

Nov 22 2007 2:17PM
Vivimed Labs Ltd.
Vivimed is uniquely positioned in the domestic home and personal care industry with no strictly comparable peer.

Oct 15 2007 10:15AM
Elder Pharmaceuticals
Elder Pharma maintains its leadership positioning in Women’s healthcare, wound care management and nutraceuticals.

Sep 28 2007 9:11AM
Bharati Shipyard Ltd
Expansion of facilities to facilitate execution of large orderbook

Sep 24 2007 8:25AM
Indoco Remedies Ltd.
The exports business of the company largely comprises of contract manufacturing for European (including UK & Germany) players.

      Pages : << Prev    |  2    
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Charting
 
Customer Service
 
Contact Us
 
Site Map
 







SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in | Media Center
Copyright© 2008. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected] 44